INVITATION | SATELLITE SYMPOSIUM
Eager to discover more about thereal-world experience and journeyof our experts with evolving PKU
management strategies?

Come join our expert facultyat the panel discussion

PKU management in evolution:
Discussion on the changing soundscapeWednesday, 4 September 2024
18:30-19:30 hrs | Camellia Auditorium, Level 0

ProgrammeWith new data emerging from both clinical trials and real-world observations, the managementof PKU is ever evolving. The advancements over the years allow healthcare professionals and theirpatients with PKU to reach new goals beyond sustained phenylalanine (Phe) control.
During this symposium, the expert panel will share their personal experiences in navigating thischanging PKU management landscape, followed by a roundtable panel discussion addressing
important questions/hurdles they encountered during the past years. In the last part of thesymposium, our expert panel welcomes you to submit your questions or share your views.

PanelJohannes Krämer

Júlio César Rocha

Ania Muntau

Valentina Rovelli

Ulm University Medical School,Ulm, Germany
University Children’s Hospital, University
Medical Center Hamburg-Eppendorf,Hamburg, Germany
This symposium has been initiated, organised and funded byNOVA Medical School & Reference Centre
for IMD, ULS S. José, Lisbon, Portugal
San Paolo Hospital, Universityof Milan, Milan, Italy

This symposium will include information
on BioMarin medicines and is intendedfor Healthcare Professionals registeredfor SSIEM 2024.

PKU management in evolution:
Discussion on the changing soundscapeWednesday, 4 September 2024
18:30-19:30 hrs | Camellia Auditorium, Level 0Johannes Krämer
Ulm University MedicalSchool, Ulm, Germany

Dr. Krämer is Senior Physician at the Division ofPaediatric Neurology and Inborn Errors of Metabolism,
Ulm University Medical School, Ulm, Germany. As aspecialist in neuropaediatrics, he is involved in thetreatment of children with epilepsy and metabolic
disorders, including PKU.

Ania Muntau

Prof. Muntau is Chair of Pediatrics and Director of
University Children’s Hospital, the Children’s Hospital at University Medical Center
University Medical Center
Hamburg-Eppendorf, Hamburg, Germany. Her research
Hamburg-Eppendorf
group focusses on the elucidation of the molecularHamburg, Germany
basis of different genetic protein misfolding diseases,
including PKU, and on the development of therapeuticstrategies for patients suffering from these diseases.
Dr. Rocha is Professor of Nutrition and Metabolism at
NOVA Medical School and is involved in the care ofPKU patients as clinical nutritionist at the ReferenceCentre of Inherited Metabolic Diseases at ULS São José,Lisbon, Portugal. He also works as researcher at theComprehensive Health Research Centre (CHRC) andCentre for Health Technology and Services Research(CINTESIS), where his research focus lies on exploring
the relationship between nutrition and metabolism.

Valentina RovelliDr. Rovelli is the leading Metabolic Specialist at theClinical Department of Paediatrics, San Paolo Hospital,
University of Milan, Italy. Her major areas of expertiseand research interests lie in the diagnosis, treatment
and understanding of underlying mechanisms ofinborn errors of metabolism, especially for patientsaffected with PKU, from neonatal to adult age.

NOVA Medical School &Reference Centre for IMD,ULS S. José, Lisbon, Portugal

San Paolo Hospital,
University of Milan, Milan,
Italy

This symposium has been initiated, organised and funded bywww.pkumeetings.com

EUCAN-PAL-00107 - June 2024Júlio César Rocha